Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Ovarian cancer remains one of the most lethal gynecologic malignancies, largely because of late-stage diagnosis and the absence of reliable biomarkers for early detection and therapeutic stratification. Recent advances in high-throughput technologies have enabled multi-omics approaches that integrate genomics, transcriptomics, proteomics, metabolomics, and epigenomics to elucidate the comprehensiv...
PURPOSE: To predict the genetic subtypes of adult-type diffuse gliomas with three-class MRI radiomics. MATERIAL AND METHODS: Four hundred and eighty patients with pathologically proved diffuse gliomas from our institution were randomly divided into training set (n = 336) and internal validation set (n = 144) according to a ratio of 7 to 3, and 105 patients from the cancer imaging archive (TCIA) we...
INTRODUCTION: Residual lesions after transurethral resection of bladder tumor (TURBT) are a major contributor to recurrence in bladder cancer. Advance...
BACKGROUND: Cystic fibrosis (CF) monitoring relies on computed tomography (CT), but ultra-short echo time MRI (UTE-MRI) offers a radiation-free altern...
BACKGROUND: Exosomal long non-coding RNA (lncRNA) as a burgeoning biomarker, its abnormal expression is closely related to the progression of cancer. ...
Cancer and autoimmune diseases are major global health challenges characterized by molecular and clinical heterogeneity. Traditional single-analyte bi...
OBJECTIVES: To develop and evaluate automated segmentation models for the liver and hepatic tumors on 18F-fluorodeoxyglucose positron emission tomogra...
BACKGROUND AND OBJECTIVE: Accurate preoperative prediction of microvascular invasion (MVI) and survival risk is essential for personalized treatment i...
High-dose methotrexate for pediatric cancer treatment is frequently associated with mucositis, which can lead to delayed or discontinued treatment and...
BACKGROUND: Clinical trials are essential for advancing cancer care, but identifying eligible patients in surgical clinics can be challenging due to t...
OBJECTIVES: Exclusive enteral nutrition (EEN) is a first-line treatment for induction of remission in luminal pediatric Crohn disease (pCD). However, ...
Artificial intelligence (AI) powered mobile health (mHealth) apps are emerging as vital self-triage tools for skin cancer detection. By utilizing smar...
Breast cancer remains a leading threat to women's health worldwide and reducing mortality hinges on early detection. Contrast-enhanced ultrasound (CEU...
PURPOSE: The use of neuronavigation with superimposed mapping tools has enabled visualization of key fiber tracts and improved peri-operative planning...
OBJECTIVE: Achieving submillimetric accuracy in stereotactic neurosurgery remains critical for safely targeting deep brain structures. Current workflo...
PURPOSE: As survival improves for patients with brain metastases (BM), distinguishing local recurrence (LR) from radionecrosis (RN) is a growing neuro...
Breast cancer is the most common cancer among women, and metastasis to the lung is associated with poor prognosis. Reliable biomarkers for predicting ...
BACKGROUND: Hepatocellular carcinoma (HCC) remains a therapeutic challenge due to high post-resection recurrence rates and heterogeneous outcomes. We ...
Lung cancer's metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulati...
Over 95% of head and neck cancers are squamous cell carcinoma (HNSCC). HNSCC is mostly diagnosed late, causing a poor prognosis despite the applicatio...